NIH-funded research R15 grant

Overcoming glutamate-driven brain damage during metabolic stress

Official title: Overcoming glutamate excitotoxicity to metabolic stress

Funded at Wake Forest University · NIH-11505830 · Data updated 2026-11-12

A researcher at Wake Forest University is studying how the brain can avoid damaging glutamate surges during metabolic stress, with potential relevance to Alzheimer’s and other neurodegenerative diseases.

Quick facts

Grant typeR15 grant
Study typeNIH-funded research
Funding institutionWake Forest University
NIH-funded
Lab location1 site (Winston-Salem, United States)
Project startSeptember 3, 2026
Project endAugust 31, 2029
Funding year2026
Award (this year)$533,623
NIH project number1R15NS149157-01A1
Project IDNIH-11505830 on NIH RePORTER

Who could benefit from this research

Could help

Patients with Alzheimer’s disease or related dementias could benefit from future therapies stemming from this research.

Less likely to help

If the mechanisms identified do not translate to humans, immediate patient benefit may be limited.

What this research studies

This project looks at how neurons can stay alive when energy is low and glutamate levels rise in the brain. By comparing a unique avian system that naturally avoids this toxic cascade, the team aims to uncover mechanisms that protect glutamate transport and boost inhibitory signaling. The study will use techniques like patch-clamp recordings, behavioral tests, and high-resolution imaging to test whether maintaining glutamate transport and enhancing GABAergic signaling can prevent neuron death during energetic stress. Training opportunities will be integrated into the research plan to teach researchers hands-on experimental methods. The goal is to translate these insights into new strategies for protecting brain cells in conditions such as Alzheimer’s disease and related dementias.

Why it matters

Potential benefit: If successful, the work could lead to new approaches to reduce brain cell loss from metabolic stress and neurodegenerative diseases.

How similar studies have gone: Previous work in other systems suggests that modulating glutamate transport and GABA signaling can influence neuronal survival under stress, but applying this to human disease is still exploratory.

Where this research is happening

  • Wake Forest University
    Winston-Salem, United States
    Active

Researchers

  • Principal investigator: Do Amaral Silva, Lara — Wake Forest University
  • Study coordinator: Do Amaral Silva, Lara

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.